MECOM and endometrial cancer: In the third study, Lou et al demonstrated that MECOM knockout in endometrial cancer cell lines resulted in reduced cell proliferation, migration and increased apoptosis; while MECOM overexpression resulted in the opposite, validating MECOM’s role in endometrial cancer tumorigenesis (Lou, 2024).